Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001041062-25-000097
Filing Date
2025-05-14
Accepted
2025-05-14 13:14:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4905
  Complete submission text file 0001041062-25-000097.txt   6940
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Subject) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-50223 | Film No.: 25944182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037 8587550239
BRANDES INVESTMENT PARTNERS, LP (Filed by) CIK: 0001015079 (see all company filings)

EIN.: 330704072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G